Augmented instructions : analysis of performance and efficiency of assembly tasks

Augmented Reality (AR) technology makes it possible to present information in the user’s line of sight, right at the point of use. This brings the capability to visualise complex information for industrial maintenance applications in an effective manner, which typically rely on paper instructions and tacit knowledge developed over time. Existing research in AR instruction manuals has already shown its potential to reduce the time taken to complete assembly tasks, as well as improving accuracy [1–3]. In this study, the outcomes of several aspects of AR instructions are explored and their effects on the chosen Key Performance Indicators (KPIs) of task completion time, error rate, cognitive effort and usability are assessed. A standardised AR assembly task is also described for performance comparison, and a novel AR experimental tool is presented, which takes advantage of the flexibility of internet connected peripherals, to explore various different aspects of AR app design to isolate their effects. Results of the experiments are given here, providing insight into the most effective way of delivering information and promoting interaction between user and computer, in terms of user performance and acceptance

Primary skin fibroblasts as a model of Parkinson's disease

Parkinson's disease is the second most frequent neurodegenerative disorder. While most cases occur sporadic mutations in a growing number of genes including Parkin (PARK2) and PINK1 (PARK6) have been associated with the disease. Different animal models and cell models like patient skin fibroblasts and recombinant cell lines can be used as model systems for Parkinson's disease. Skin fibroblasts present a system with defined mutations and the cumulative cellular damage of the patients. PINK1 and Parkin genes show relevant expression levels in human fibroblasts and since both genes participate in stress response pathways, we believe fibroblasts advantageous in order to assess, e.g. the effect of stressors. Furthermore, since a bioenergetic deficit underlies early stage Parkinson's disease, while atrophy underlies later stages, the use of primary cells seems preferable over the use of tumor cell lines. The new option to use fibroblast-derived induced pluripotent stem cells redifferentiated into dopaminergic neurons is an additional benefit. However, the use of fibroblast has also some drawbacks. We have investigated PARK6 fibroblasts and they mirror closely the respiratory alterations, the expression profiles, the mitochondrial dynamics pathology and the vulnerability to proteasomal stress that has been documented in other model systems. Fibroblasts from patients with PARK2, PARK6, idiopathic Parkinson's disease, Alzheimer's disease, and spinocerebellar ataxia type 2 demonstrated a distinct and unique mRNA expression pattern of key genes in neurodegeneration. Thus, primary skin fibroblasts are a useful Parkinson's disease model, able to serve as a complement to animal mutants, transformed cell lines and patient tissues